Investors expect a surge in deal activity in 2026 as drug makers look to replenish pipelines and capitalize on low interest ...

Artificial-intelligence-powered drug developer Insilico Medicine is set for a $10 million upfront payment from a fresh-faced ...

From cutting-edge solutions for stem cell research to 3D multi-omics for rapid identification of drug targets, this edition ...

The company made an even more dramatic claim the following month, when it announced it had created three dire wolves. These ...

Both biotechs are a bit risky, but could benefit from clinical progress this year -- and the upside would be huge. CRISPR has ...

So far this month, investors have poured $2.6 billion into follow-on rounds for public biotechs — the most ever for the ...

At some point in your research career, you may find yourself transitioning from academia to industry or vice versa. To best ...

Genentech, a biotechnology company that pledged last year to build a manufacturing facility in southern Wake County, said it ...

The biotech sector is one that’s become red-hot, at least in recent years. After around a decade of stagnation, investors ...

We all know someone waiting on a medical breakthrough. It could be a parent battling a chronic illness, a colleague pushing ...

Attend or sponsor our commercial real estate event in San Diego: Southern California Life Sciences & Biotech Summit.

The discussion focuses on how KAIMRC integrates clinical research, biobanking, data infrastructure, and translational science ...